000 | 01928 a2200601 4500 | ||
---|---|---|---|
005 | 20250515021647.0 | ||
264 | 0 | _c20061030 | |
008 | 200610s 0 0 eng d | ||
022 | _a0887-6924 | ||
024 | 7 |
_a10.1038/sj.leu.2404195 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTrbusek, M | |
245 | 0 | 0 |
_aInactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment. _h[electronic resource] |
260 |
_bLeukemia _cJun 2006 |
||
300 |
_a1159-61 p. _bdigital |
||
500 | _aPublication Type: Letter; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAtaxia Telangiectasia Mutated Proteins |
650 | 0 | 4 |
_aCell Cycle Proteins _xgenetics |
650 | 0 | 4 |
_aDNA-Binding Proteins _xgenetics |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aGene Deletion |
650 | 0 | 4 | _aGenes, Neoplasm |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunoglobulin Heavy Chains _xgenetics |
650 | 0 | 4 |
_aImmunoglobulin Variable Region _xgenetics |
650 | 0 | 4 |
_aLeukemia, Lymphocytic, Chronic, B-Cell _xdiagnosis |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aPoint Mutation |
650 | 0 | 4 |
_aProtein Serine-Threonine Kinases _xgenetics |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
700 | 1 | _aMalcikova, J | |
700 | 1 | _aSmardova, J | |
700 | 1 | _aKuhrova, V | |
700 | 1 | _aMentzlova, D | |
700 | 1 | _aFrancova, H | |
700 | 1 | _aBukovska, S | |
700 | 1 | _aSvitakova, M | |
700 | 1 | _aKuglik, P | |
700 | 1 | _aLinkova, V | |
700 | 1 | _aDoubek, M | |
700 | 1 | _aBrychtova, Y | |
700 | 1 | _aZacal, J | |
700 | 1 | _aKujickova, J | |
700 | 1 | _aPospisilova, S | |
700 | 1 | _aDvorakova, D | |
700 | 1 | _aVorlicek, J | |
700 | 1 | _aMayer, J | |
773 | 0 |
_tLeukemia _gvol. 20 _gno. 6 _gp. 1159-61 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.leu.2404195 _zAvailable from publisher's website |
999 |
_c16179221 _d16179221 |